What Breast Cancer Patients Need When Treatment Ends
Breast cancer awareness is at an all-time high, particularly during October, which is designated as Breast Cancer Awareness Month. Despite the heightened awareness, there is a significant gap in the support and resources available to patients after their treatment concludes. Dr. Marisa Weiss, founder and Chief Medical Officer of Breastcancer.org, emphasizes that while public knowledge around early diagnosis and risk factors has improved, the post-treatment landscape remains unclear and often overwhelming for survivors.
According to the World Health Organization, breast cancer continues to be the leading cause of cancer-related deaths among women globally, with approximately 694,000 fatalities and 8.2 million women currently living with a breast cancer diagnosis. As the focus on awareness campaigns fades after October, many survivors find themselves grappling with unanswered questions and unresolved fears about their health and future.
Dr. Weiss, who has dedicated over 30 years to treating breast cancer patients, also has personal experience as a survivor herself, having been diagnosed with stage 1 breast cancer in 2000. This dual perspective informs her advocacy and her understanding of the challenges faced by patients in the aftermath of treatment.
She notes that while awareness is beneficial, it often fails to translate into adequate support for survivors. “Many people believe breast cancer affects others but not their own families,” Dr. Weiss explains, stressing that 85% to 90% of breast cancer cases occur in individuals without a known family history of the disease. This misconception leaves many feeling unprepared when the diagnosis comes.
The transition from treatment to what is often called the “quiet phase” can be particularly isolating. Patients frequently experience a surge of practical and emotional questions, such as how to manage lingering side effects, return to work, or communicate with their families about their experiences. This period is marked by a sense of uncertainty, as many struggle to redefine their lives in a post-cancer context.
Dr. Weiss identifies a critical gap in care during this time. Many patients turn to alternative therapies—such as supplements, GLP-1s, and even medical cannabis—without discussing these choices with their healthcare providers, often out of fear of being judged or misunderstood. This lack of communication can lead to harmful interactions with ongoing treatments and underscores the need for open dialogues between patients and their medical teams.
Peer support groups and online communities can offer valuable resources, but Dr. Weiss cautions that personal experiences vary widely, and what works for one individual may not be suitable for another. She encourages patients to be proactive advocates for their health, urging them to prepare for medical appointments by documenting their medical histories, questions, and personal circumstances that may impact their care.
As the field of medicine evolves, Dr. Weiss expresses cautious optimism about the role of artificial intelligence in improving breast cancer diagnosis and treatment. However, she warns against the risks of misinformation, particularly in an age where patients often seek answers online.
Her final advice for survivors preparing for medical appointments is to come equipped with questions, bring a trusted companion for support, and remain engaged in the conversation. “Every question is valid when it concerns your health,” she insists, highlighting the importance of being informed and prepared to navigate the complexities of post-treatment life.
For breast cancer survivors, the journey does not end with treatment; it requires continuous advocacy, education, and support to ensure a fulfilling and healthy future.
